186 related articles for article (PubMed ID: 8580807)
21. GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome.
Pine SR; Guo Q; Yin C; Jayabose S; Levendoglu-Tugal O; Ozkaynak MF; Sandoval C
Leuk Res; 2005 Nov; 29(11):1353-6. PubMed ID: 15916804
[TBL] [Abstract][Full Text] [Related]
22. Transient leukemia in newborns with Down syndrome.
Massey GV
Pediatr Blood Cancer; 2005 Jan; 44(1):29-32. PubMed ID: 15558701
[TBL] [Abstract][Full Text] [Related]
23. Telomerase and the benign and malignant megakaryoblastic leukemias of Down syndrome.
Holt SE; Brown EJ; Zipursky A
J Pediatr Hematol Oncol; 2002 Jan; 24(1):14-7. PubMed ID: 11902731
[TBL] [Abstract][Full Text] [Related]
24. Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome.
Zipursky A; Brown E; Christensen H; Sutherland R; Doyle J
Semin Perinatol; 1997 Feb; 21(1):97-101. PubMed ID: 9190039
[TBL] [Abstract][Full Text] [Related]
25. Acute megakaryoblastic leukemia following transient myeloproliferative disorder in a patient without Down syndrome.
Brissette MD; Duval-Arnould BJ; Gordon BG; Cotelingam JD
Am J Hematol; 1994 Dec; 47(4):316-9. PubMed ID: 7977305
[TBL] [Abstract][Full Text] [Related]
26. Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children's Oncology Group Study POG 9421.
O'Brien MM; Cao X; Pounds S; Dahl GV; Raimondi SC; Lacayo NJ; Taub J; Chang M; Weinstein HJ; Ravindranath Y; Inaba H; Campana D; Pui CH; Rubnitz JE
Leukemia; 2013 Mar; 27(3):731-4. PubMed ID: 22918081
[No Abstract] [Full Text] [Related]
27. A neonate with a unique non-Down syndrome transient proliferative megakaryoblastic disease.
Bertrums EJ; Buijs A; van Grotel M; Dors N; de Rooij JD; de Haas V; Hopman S; Jongmans MC; Zwaan CM; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27667142
[TBL] [Abstract][Full Text] [Related]
28. Distinct gene signatures of transient and acute megakaryoblastic leukemia in Down syndrome.
Lightfoot J; Hitzler JK; Zipursky A; Albert M; Macgregor PF
Leukemia; 2004 Oct; 18(10):1617-23. PubMed ID: 15343346
[TBL] [Abstract][Full Text] [Related]
29. [Acute megakaryoblastic leukemia in Down syndrome with 3 q-, dominated by tumor formation and myelofibrosis].
Hasegawa N; Hoshina H; Kudo H; Enomoto Y; Hayashi Y
Rinsho Ketsueki; 1988 Nov; 29(11):2079-85. PubMed ID: 2976850
[No Abstract] [Full Text] [Related]
30. [The molecular mechanism of leukemogenesis in Down syndrome-related acute megakaryocytic leukemia].
Ito E; Toki T
Nihon Rinsho; 2007 Jan; 65 Suppl 1():136-40. PubMed ID: 17476742
[No Abstract] [Full Text] [Related]
31. Chromosome 7 abnormalities in acute megakaryoblastic leukemia associated with Down syndrome.
Kobayashi K; Usami I; Kubota M; Nishio T; Kakazu N
Cancer Genet Cytogenet; 2005 Apr; 158(2):184-7. PubMed ID: 15796967
[TBL] [Abstract][Full Text] [Related]
32. [Congenital acute megakaryoblastic leukemia associated with trisomy 21].
Gomis F; Pérez Sirvent ML; Borrego D; Sempere A
Sangre (Barc); 1990 Dec; 35(6):485-6. PubMed ID: 2150895
[No Abstract] [Full Text] [Related]
33. A t(1;22)(p13;q13) in four children with acute megakaryoblastic leukemia (M7), two with Down syndrome.
Trejo RM; Aguilera RP; Nieto S; Kofman S
Cancer Genet Cytogenet; 2000 Jul; 120(2):160-2. PubMed ID: 10942809
[TBL] [Abstract][Full Text] [Related]
34. Megakaryoblastic disorders in children.
Lorsbach RB
Am J Clin Pathol; 2004 Dec; 122 Suppl():S33-46. PubMed ID: 15690641
[TBL] [Abstract][Full Text] [Related]
35. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.
Wechsler J; Greene M; McDevitt MA; Anastasi J; Karp JE; Le Beau MM; Crispino JD
Nat Genet; 2002 Sep; 32(1):148-52. PubMed ID: 12172547
[TBL] [Abstract][Full Text] [Related]
36. Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome.
Boztug H; Schumich A; Pötschger U; Mühlegger N; Kolenova A; Reinhardt K; Dworzak M
Cytometry B Clin Cytom; 2013; 84(6):370-8. PubMed ID: 23450818
[TBL] [Abstract][Full Text] [Related]
37. Acute Megakaryocytic Leukemia.
McNulty M; Crispino JD
Cold Spring Harb Perspect Med; 2020 Feb; 10(2):. PubMed ID: 31548219
[TBL] [Abstract][Full Text] [Related]
38. [Acute megakaryoblastic leukemia. Relation to trisomy 21].
Levaltier X; Reman O; Boutard P; Mandard JC; Troussard X; Leporrier M
Arch Fr Pediatr; 1991 Oct; 48(8):563-6. PubMed ID: 1837448
[TBL] [Abstract][Full Text] [Related]
39. Mosaic Down syndrome-associated acute myeloid leukemia does not require high-dose cytarabine treatment for induction and consolidation therapy.
Kudo K; Hama A; Kojima S; Ishii R; Morimoto A; Bessho F; Sunami S; Kobayashi N; Kinoshita A; Okimoto Y; Tawa A; Tsukimoto I
Int J Hematol; 2010 May; 91(4):630-5. PubMed ID: 20237876
[TBL] [Abstract][Full Text] [Related]
40. Leukemia in Down syndrome: a review.
Zipursky A; Poon A; Doyle J
Pediatr Hematol Oncol; 1992; 9(2):139-49. PubMed ID: 1388043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
